Registration Open for ICTO 2026: 9th Edition of International Conference on Clinical & Translational Oncology

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce that Registration is Open Now for the:

🌍 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026), organized by Magnus Group.

📅 08–10 October 2026
📍 Tokyo, Japan | Hybrid Event

Join leading researchers, clinicians, oncologists, healthcare professionals, and experts from around the world to exchange knowledge, explore recent advances, and discuss emerging developments in clinical and translational oncology.

🔬 Be part of this global scientific platform!

👉 Register Now:
https://magnusconferences.com/cancer-oncology/

🔗 More Information: https://magnusconferences.com/cancer-oncology/

📧 cancer@magnusconference.com

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #MedicalConference #Healthcare #CancerResearch2026 #Tokyo #Japan #HybridConference #MagnusConferences

Paulraj S to Present HIF-Targeted Cancer Therapy Research at ICTO 2026

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to welcome Paulraj S from Chennai Snake Park Trust, India, as an Oral Presenter at the 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

🔬 Presentation Title:
“Targeting hypoxia inducible factor (HIF) through synergetic actions of active molecules found in some functional foods, an effective cancer therapy”

📅 08–10 October 2026
📍 Tokyo, Japan | Hybrid Event

Join researchers, clinicians, healthcare professionals, and oncology experts from around the world for valuable scientific discussions and knowledge exchange.

🌐 Learn more: https://magnusconferences.com/cancer-oncology/

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #CancerTherapy #OncologyConference #CancerResearchConference #HIF #FunctionalFoods #TokyoJapan #MagnusConferences

Early Bird Registration Closing Soon for ICTO 2026 in Tokyo, Japan

 🎗️ Early Bird Registrations Are Closing Soon! 🎗️

📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

🌍 Connect with leading researchers, clinicians, healthcare professionals, academicians, and industry experts from around the world.

🔬 Why participate?
• Share your research and scientific insights
• Connect with global oncology professionals
• Explore the latest developments in clinical & translational oncology
• Participate in person or virtually

⏰ Early Bird Registration Deadline Is Approaching!
Secure your participation before early bird registration closes.

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

📧 cancer@magnusconference.com 

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🌐 https://magnusconferences.com/cancer-oncology/ 

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerResearchConference #OncologyConference #MedicalConference #Tokyo #EarlyBirdRegistration

Abstract Submission Closing Soon for ICTO 2026 in Tokyo, Japan

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

🎗️ Abstract Submission – Closing Soon! 🎗️

We are pleased to announce the 1st Round of Abstract Submission for the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026).

🗓️ 08–10 October 2026
📍 Tokyo, Japan
🌐 Hybrid Event

🔬 Share your latest research, clinical insights, and innovations with an international community of oncology professionals and researchers.

⏳ Abstract Submission Closes Soon!

📧 Email: cancer@magnusconference.com
🌐 Website: magnusconferences.com/cancer-oncology/

📞 Phone: +1 (702) 988 2320
💬 WhatsApp: +1 (640) 666 9566

👉 Submit your abstract and be part of ICTO 2026!

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #Oncology #ClinicalOncology #TranslationalOncology #CancerResearch #CancerConference #AbstractSubmission #OncologyConference #MedicalConference #Tokyo #Japan #HybridConference

ICTO 2026 Welcomes Michael Thompson as Keynote Speaker to Highlight Innovative Ovarian Cancer Biomarker Detection

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

🎤 Keynote Speaker Spotlight | ICTO 2026

We are pleased to welcome Michael Thompson from the University of Toronto, Canada, as a Keynote Speaker (Virtual) at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026).

🔬 Keynote Presentation:
“Electrochemical multiplexing strategies for point-of-care detection of ovarian cancer biomarkers”

His presentation will explore innovative electrochemical approaches for the point-of-care detection of ovarian cancer biomarkers, highlighting the potential of translational technologies in advancing cancer diagnosis.

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

🌐 Join leading researchers, clinicians, scientists, and oncology professionals from around the world at ICTO 2026.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OvarianCancer #CancerBiomarkers #Oncology #KeynoteSpeaker #MedicalResearch #TokyoJapan

ICTO 2026 Tokyo, Japan | International Conference on Clinical & Translational Oncology – October 8–10, 2026

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

The conference brings together researchers, clinicians, scientists, and oncology professionals to exchange knowledge, present groundbreaking research, and explore advances in cancer care and research.

🧬 General Scientific Sessions include:
• Cancer Biology
• Types of Cancer
• Cancer Detection and Diagnosis
• Cancer Treatments
• Case Reports
• Prevention and Epidemiology
• Cancer Genetics and Genomics
• Palliative Care and Supportive Oncology
• Cancer Research and Clinical Trials
• Survivorship and Long-Term Care
• Future Directions in Cancer Research
• Translational and Clinical Cancer Research

🌏 Join us in Tokyo or participate virtually and be part of the global oncology community.

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

📩 Email: cancer@magnusconference.com
🌐 Website: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #CancerBiology #CancerGenomics #ClinicalTrials #Oncology #MedicalResearch #TokyoJapan #HybridConference #MagnusGroup

ICTO 2026 – 9th Edition of the International Conference on Clinical & Translational Oncology

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place on October 8–10, 2026, in Tokyo, Japan, and Online as a Hybrid Event.

Registrations are open now!

ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, scientists, and industry experts from around the world to share knowledge, present research, discuss emerging developments, and explore the latest advances in oncology.

The conference provides an excellent platform for professionals working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields to present their latest findings and engage with the international oncology community.

Participants will have the opportunity to:

🔬 Present and discuss the latest oncology research
🧬 Explore advances in clinical and translational oncology
🎗️ Share innovative approaches to cancer research and care
💡 Discover emerging developments and technologies
🤝 Connect and collaborate with researchers and healthcare professionals worldwide
🌍 Engage with the global oncology community through a hybrid format

Researchers, clinicians, healthcare professionals, academics, and industry experts are invited to participate and contribute to this international scientific gathering.

📌 Conference Details

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event
🏢 Hosted by: Magnus Group

🎟️ Registrations are open now!

Join ICTO 2026 and be part of an international platform dedicated to advancing clinical and translational oncology.

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

📧 Email: cancer@magnusconference.com
🌐 Website: Magnus Group – International Conference on Clinical & Translational Oncology

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #PrecisionMedicine #MedicalResearch #OncologyResearch #CancerScience #Tokyo #Japan #HybridEvent #MagnusGroup

ICTO 2026 – Distinguished Keynote Presentation

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to welcome Jianhua Luo from the University of Pittsburgh School of Medicine, United States, as a distinguished Keynote Presenter at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group.

As part of the scientific program, Jianhua Luo will deliver an insightful keynote presentation titled:

“Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses”

The presentation will highlight emerging approaches in hepatocellular carcinoma, focusing on the potential of fusion gene detection and machine learning analyses to enhance clinical outcome prediction and support advances in cancer research.

ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, and industry experts from around the world to exchange knowledge, discuss emerging developments, present innovative research, and explore new opportunities in clinical and translational oncology.

The conference provides an international platform to engage with experts, discover advances in cancer research and care, and foster meaningful scientific and professional collaborations.

📌 Keynote Presenter: Jianhua Luo
🏛️ Affiliation: University of Pittsburgh School of Medicine, United States
🎤 Presentation: Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Join ICTO 2026 and be part of an international scientific gathering advancing the future of clinical and translational oncology.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #KeynoteSpeaker #ClinicalOncology #TranslationalOncology #CancerResearch #HepatocellularCarcinoma #MachineLearning #OncologyConference #PrecisionOncology #CancerCare #MedicalResearch

🌟 Why Wait? Register Early for ICTO 2026!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Make the most of your participation at ICTO 2026 – 9th Edition of the International Conference on Clinical & Translational Oncology.

🎟️ Catch the Early Bird Advantage!

• Save with Early Bird registration rates
• Connect with global oncology experts
• Discover the latest advances in cancer research
• Participate in scientific sessions and discussions
• Expand your professional network

📅 October 8–10, 2026
📍 Tokyo, Japan
🌐 Hybrid Event

⏳ Don’t miss the Early Bird opportunity! Register early and save more.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and connect with the global oncology community.

#ICTO2026 #EarlyBirdRegistration #OncologyConference #ClinicalOncology #TranslationalOncology #CancerResearch #TokyoJapan

⏰ Early Bird Registrations Are Closing Soon!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

⏰ Early Bird Registrations Are Closing Soon!

We are pleased to invite you to the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

Early Bird Registrations are closing soon, providing participants with an opportunity to register early and benefit from the special early registration rates.

ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, scientists, and industry experts from around the world to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Professionals and researchers working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to participate in this international scientific gathering.

The conference offers an excellent opportunity to exchange knowledge, explore emerging developments in oncology, present research, build professional connections, and engage with experts from around the world.

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

⏰ Early Bird Registrations Are Closing Soon – Register Now!

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and be part of the global oncology community.

🎟️ Register early and save more!

👉 Visit the ICTO 2026 Official Website

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #PrecisionMedicine #MedicalResearch #EarlyBirdRegistration #OncologyConference2026 #HybridConference #TokyoConference

ICTO 2026 – 9th Edition of the International Conference on Clinical & Translational Oncology

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Researchers and professionals working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to submit their abstracts and contribute to this international scientific gathering.

The conference offers an opportunity to exchange knowledge, explore emerging developments in oncology, build professional connections, and engage with experts from around the world.

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Join ICTO 2026 and be part of the global oncology community.

🎟️ Register early and save more!

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #PrecisionMedicine #MedicalResearch

⏳ 1st Round of Abstract Submission Closes Soon! – ICTO 2026!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Researchers and professionals working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to submit their abstracts and contribute to this international scientific gathering.

🔗 Learn more about ICTO 2026:

https://magnusconferences.com/cancer-oncology/

📝 Submit your Abstract:

https://magnusconferences.com/cancer-oncology/submit-abstract

👉 Register for ICTO 2026:

https://magnusconferences.com/cancer-oncology/register

📞 Phone: +1 (702) 988-2320

📱 WhatsApp: +1 (640) 666 9566

📧 Email: cancer@magnusconferences.com

🌟 Join ICTO 2026 and share your research with the global clinical and translational oncology community!

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerCare #MedicalResearch #CancerConference #AbstractSubmission #TokyoJapan #Healthcare #ResearchConference

Call for Papers: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled to take place on October 8–10, 2026, in Tokyo, Japan, as a hybrid event offering both in-person and virtual participation organized by Magnus Group.

The conference brings together researchers, clinicians, healthcare professionals, academicians, scientists, and industry experts to exchange knowledge, present innovative research, and discuss emerging developments in clinical and translational oncology.

Why Participate?

ICTO 2026 provides an international platform to:

• Present original research and recent scientific findings
• Exchange knowledge with oncology professionals and researchers
• Discuss emerging advances in clinical and translational oncology
• Build international academic and professional collaborations
• Explore developments that can help bridge laboratory research and clinical applications

📄 Call for Papers

Researchers and professionals are invited to submit their papers and research contributions for consideration at the conference.

Conference: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)
Dates: October 8–10, 2026
Location: Tokyo, Japan
Format: Hybrid Event

For conference information and paper submission details, visit: https://magnusconferences.com/cancer-oncology/

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

Join ICTO 2026 and be part of an international scientific platform dedicated to advancing clinical and translational oncology.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerResearch2026 #CallForPapers #MedicalResearch #TokyoJapan #HealthcareInnovation #MagnusConferences

Keynote Speaker Yan Leyfman to Discuss Large Language Models in Oncology at ICTO 2026

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

🌟 We are delighted to announce Yan Leyfman from NYP – Meyer Cancer Center, United States, as a Keynote Speaker at the 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group.

Yan Leyfman will deliver a keynote presentation titled:

🎤 “Real-world clinician adoption and disease-specific safety failures of large language models in oncology clinical decision support.”

The presentation will explore an important area at the intersection of large language models, artificial intelligence, clinical decision support, and oncology, focusing on real-world clinician adoption and disease-specific safety considerations.

🔗 Learn more about the 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026): https://magnusconferences.com/cancer-oncology/

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

👉 Register for ICTO 2026: https://magnusconferences.com/cancer-oncology/register

📞 Phone: +1 (702) 988-2320
📱 WhatsApp: +1 (640) 666 9566
📧 Email: cancer@magnusconferences.com

For more updates, follow our ICTO 2026 Blog.

#ICTO2026 #YanLeyfman #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #ArtificialIntelligence #LargeLanguageModels #LLM #ClinicalDecisionSupport #HealthcareAI

ICTO 2026 – International Conference on Clinical & Translational Oncology

 The 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026) will take place on October 8–10, 2026, in Tokyo, Japan, with an option for participants to join virtually as part of the hybrid conference organized by Magnus Group.

From Prevention to Survivorship: A Cancer Care Continuum

ICTO 2026 focuses on the evolving landscape of cancer care and the importance of connecting research, clinical practice, and translational approaches across the cancer care continuum.

The conference provides an international platform for oncologists, clinicians, researchers, academicians, healthcare professionals, scientists, and industry experts to exchange knowledge, present research findings, discuss emerging technologies, and explore innovative approaches in cancer care.

Why Attend ICTO 2026?

Participants will have opportunities to:

• Explore recent advances in clinical and translational oncology.
• Share research findings and scientific perspectives.
• Connect with international oncology and healthcare professionals.
• Discuss emerging approaches in cancer prevention, diagnosis, and treatment.
• Exchange ideas on improving patient care and survivorship.
• Build professional and research collaborations.

Conference Details

Conference: 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026)
Date: October 8–10, 2026
Location: Tokyo, Japan
Format: Hybrid – In-person & Virtual
Theme: From Prevention to Survivorship: A Cancer Care Continuum

Researchers and professionals interested in oncology and related disciplines are invited to participate and contribute to the scientific discussions at ICTO 2026.

Learn more, register, or submit your abstract:
https://magnusconferences.com/cancer-oncology/

#ICTO2026 #InternationalOncologyConference #CancerResearch #Oncology #ClinicalOncology #TranslationalOncology #CancerCare #MedicalResearch #HealthcareConference #TokyoConference #HybridConference

Catch the Early Bird Advantage at ICTO 2026 – International Conference on Clinical & Translational Oncology

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled for October 8–10, 2026, in Tokyo, Japan, with virtual participation available through its Hybrid Event format organized by Magnus Group.

ICTO 2026 provides an international platform for clinicians, researchers, healthcare professionals, academics, and oncology experts to exchange knowledge, present research, and explore emerging developments in clinical and translational oncology.

What to Expect at ICTO 2026?

🔬 Latest Oncology Research
Discover emerging research, innovative approaches, and developments shaping the future of oncology.

🌍 International Speakers
Gain insights from experts and professionals working across different areas of oncology and cancer research.

🧬 Scientific Sessions
Explore current developments in clinical and translational oncology through scientific presentations and discussions.

🤝 Global Networking
Connect with researchers, clinicians, healthcare professionals, and experts from around the world.

💡 Knowledge Exchange
Share research findings, experiences, and perspectives while contributing to the global oncology community.

🐦 Catch the Early Bird Advantage!

Participants are encouraged to register early and take advantage of exclusive benefits before the registration deadline.

📅 Date: October 8–10, 2026
📍 Location: Tokyo, Japan
💻 Participation: Hybrid Event – In Person & Virtual

For conference information, visit:
https://magnusconferences.com/cancer-oncology/

📧 Email: cancer@magnusconferences.com
📞 Phone: +1 (702) 988 2320
💬 WhatsApp: +1 (640) 666 9566

Register early and save more!

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

#ICTO2026 #ClinicalOncology #TranslationalOncology #OncologyConference #CancerResearch #CancerResearch2026 #MedicalConference #OncologyResearch #HybridConference #TokyoJapan #EarlyBirdRegistration

ICTO 2026: Register Early and Save More on Your Participation

The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized by Magnus Group is bringing together oncology professionals, clinicians, researchers, academics, healthcare experts, and industry professionals for three days of scientific exchange and collaboration.

The conference will be held October 8–10, 2026, in Tokyo, Japan, with a hybrid participation option, allowing attendees to participate either in person or virtually.

ICTO 2026 provides an excellent platform to present research, exchange scientific knowledge, discuss emerging developments in oncology, and build valuable professional connections with experts from around the world.

Conference Highlights

• International scientific networking
• Oral and keynote presentations
• Research and knowledge exchange
• Discussions on clinical and translational oncology
• Opportunities for collaboration
• In-person and virtual participation

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

Early registration is encouraged to take advantage of available savings.

👉 Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

For further information, contact cancer@magnusconferences.org.

#ICTO2026 #InternationalOncologyConference #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerResearchConference #MedicalConference #TokyoConference #JapanConference

🎗️ ICTO 2026: Register Now for the International Conference on Clinical & Translational Oncology

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled for 08–10 October 2026 in Tokyo, Japan, with a hybrid participation option, organized by Magnus Group.

This international conference brings together professionals and experts working across clinical oncology, cancer research, translational medicine, healthcare, and related scientific fields.

🌍 Be Part of ICTO 2026

The conference offers an opportunity for participants to present their research, exchange scientific knowledge, establish professional connections, and discuss emerging developments in oncology.

📅 Event Information

Conference: 9th Edition of the International Conference on Clinical & Translational Oncology
Date: 08–10 October 2026
Venue: Tokyo, Japan
Event Format: Hybrid Event

🔬 Who Can Participate?

ICTO 2026 welcomes participation from:

• Oncologists
• Cancer researchers
• Clinicians
• Medical professionals
• Academicians
• Healthcare professionals
• Translational medicine researchers
• Pharmaceutical and biotechnology professionals
• Students and early-career researchers

🎤 Present Your Research

Researchers and professionals can take part by submitting their abstracts for consideration and sharing their scientific work with an international audience.

👉 Submit your abstract: ICTO 2026 Abstract Submission

🌐 Register Now

Whether you plan to attend in person in Tokyo, Japan, or participate online, ICTO 2026 provides an opportunity to connect with the international oncology community.

👉 Register here: https://magnusconferences.com/cancer-oncology/register

For additional conference information, visit: https://magnusconferences.com/cancer-oncology/

📩 Contact: cancer@magnusconference.com

🎗️ Save the Date

08–10 October 2026 | Tokyo, Japan | Hybrid Event

Register now and join the global community advancing clinical and translational oncology.

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerConference #OncologyConference #CancerResearchConference #MedicalResearch #ClinicalResearch #HealthcareInnovation #CancerCare #Tokyo #Japan #HybridConference #MagnusGroup

Translational and Clinical Cancer Research – ICTO 2026

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized Magnus Group invites researchers, clinicians, oncologists, healthcare professionals, academics, and industry experts to participate in an international scientific platform dedicated to advancing cancer research.

Translational and Clinical Cancer Research

Cancer research continues to advance through strong collaboration between laboratory discoveries and clinical applications. Translational and clinical research plays a vital role in transforming scientific discoveries into improved approaches for cancer prevention, diagnosis, treatment, and patient care.

Researchers are encouraged to share their latest findings and contribute to the global discussion on the future of cancer research.

📅 Date: October 08–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Submit your research and join the international oncology community at ICTO 2026.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #TranslationalCancerResearch #ClinicalCancerResearch #CancerResearch #Oncology #ClinicalOncology #TranslationalOncology #CancerConference #CancerResearch2026 #Tokyo #HybridConference

Call for Papers: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized by Magnus Group invites researchers, clinicians, healthcare professionals, scientists, academicians, and industry experts from across the globe to submit their original research and participate in this prestigious international event.

Scheduled for October 08–10, 2026, in Tokyo, Japan, with hybrid participation options, ICTO 2026 provides an exceptional platform to discuss groundbreaking discoveries, emerging technologies, and innovative therapeutic approaches in clinical and translational oncology.

Why Attend ICTO 2026?

• Present your latest research to an international audience.
• Engage with globally recognized oncology experts.
• Build collaborations with researchers and healthcare professionals.
• Gain valuable scientific feedback.
• Explore recent advancements in cancer diagnosis, treatment, immunotherapy, precision medicine, biomarkers, and translational research.
• Network with academic institutions, hospitals, research organizations, and industry leaders.

Who Should Attend?

• Oncologists
• Cancer Researchers
• Clinical Scientists
• Medical Professionals
• Surgeons
• Pathologists
• Pharmaceutical Researchers
• Healthcare Providers
• Faculty Members
• Students
• Industry Representatives

Submit Your Abstract

Researchers are encouraged to submit original research, case studies, and review presentations.

Abstract Submission
https://magnusconferences.com/cancer-oncology/submit-abstract

Conference Details

📅 October 08–10, 2026

📍 Tokyo, Japan | Hybrid Event

Website:
https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and contribute to advancing global cancer research while connecting with distinguished experts from around the world.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #CancerConference #MedicalResearch #Oncology #HealthcareInnovation #CallForPapers #Tokyo #HybridConference #MagnusGroup